Get the Daily Brief

All action, no filler. BioBriefs delivers biotech’s 10 must-know updates, every morning.

Latest Biotech News

Discovering Gut Bacteria that May Bind PFAS Toxic ‘Forever Chemicals’

July 05, 2025

A team led by University of Cambridge researchers identified nine strains of gut bacteria capable of accumulating significant amounts of perfluoroalkyl substances (PFAS), ubiquitous environmental...

Nano-Structured Sheets Protect Against Radiation-Induced Mucositis

July 05, 2025

Researchers have engineered nanostructured organic sheets that effectively sequester extracellular vesicles and reactive oxygen species generated during radiation therapy, offering protective...

Spatial Biology Tools Illuminate Tumor Microenvironment Complexity

July 05, 2025

Cutting-edge spatial multiomics technologies integrating protein and gene expression mapping, combined with AI-driven analysis, are revolutionizing cancer research by revealing the intricate...

CRISPR Breakthrough Removes Extra Chromosome in Down Syndrome Cells

July 05, 2025

Researchers in Japan have demonstrated a pioneering use of CRISPR-Cas9 technology to remove the trisomy 21 chromosome responsible for Down syndrome in lab-grown human cells. This allele-specific...

FDA Removes REMS Restrictions for CAR-T Therapies to Boost Access

July 05, 2025

The FDA has discontinued Risk Evaluation and Mitigation Strategies (REMS) for six CAR-T cell therapies targeting BCMA and CD19, used in multiple myeloma, leukemia, and lymphoma. This decision...

Dizal’s Sunvozertinib Gains FDA Accelerated Approval in NSCLC

July 05, 2025

Dizal Pharmaceutical obtained accelerated FDA approval for sunvozertinib (Zegfrovy) to treat adults with locally advanced or metastatic non-small cell lung cancer harboring EGFR exon 20 insertion...

New Diagnostic Advances in Cancer and Neurological Diseases

July 05, 2025

Novel molecular biomarkers and approaches are emerging to enhance diagnostics and prognostics across oncology and neurology. Studies identify plasma microRNAs linked to peritoneal carcinomatosis...

Advances in Stem Cell and Regenerative Medicine Technologies

July 05, 2025

Innovative engineering of stem cell sheets with aligned cellular structures enhances protein secretion, bolstering regenerative therapies for chronic and acute conditions. Studies also report...

AI and Digital Tools Expand Healthcare Diagnostics and Research

July 05, 2025

Artificial intelligence integration significantly enhances diagnostic accuracy and adoption of novel technologies in medical practice. AI-assisted assessment improves pathologists’ interpretations...

Climate Change Impacts and Environmental Biotechnology Developments

July 05, 2025

Recent research highlights the multifaceted influence of climate change on health, ecosystems, and technology development. Studies explore the effects of global warming on infectious disease...

Innovations in Cancer Therapy and Tumor Microenvironment Modulation

July 05, 2025

Cutting-edge research unravels complex mechanisms driving tumor progression and unveils novel therapeutic targets. Investigations reveal a transcription factor regulating bladder cancer via...

Biopharma Financing and Industry Market Trends

July 05, 2025

The biotech sector displays mixed financial activity with notable fundraising rounds and stock index rebounds after earlier declines. Field Medical secured $35 million in Series B venture capital...

FDA Removes REMS from CAR T Therapies — Industry Voices Optimism

July 05, 2025

The FDA has eliminated the Risk Evaluation and Mitigation Strategies (REMS) previously required for six approved CAR T cell therapies targeting BCMA and CD19 antigens, marking a significant shift...

FDA Accelerates Dizal's Lung Cancer Drug Approval Ahead of PDUFA

July 05, 2025

The FDA granted accelerated approval to Dizal Pharmaceutical's oral drug sunvozertinib (Zegfrovy) for adults with locally advanced or metastatic non-small cell lung cancer harboring EGFR exon 20...

CRISPR Deletes Extra Chromosome in Down Syndrome Cells for First Time

July 05, 2025

A team at Mie University in Japan has successfully used CRISPR-Cas9 technology to selectively remove the extra chromosome 21 responsible for Down syndrome in laboratory-grown human cells. This...

AI Model AlphaGenome Integrates Multimodal Genomic Predictions

July 05, 2025

Google DeepMind introduced AlphaGenome, an AI foundation model that simultaneously predicts diverse genomic features such as gene expression, RNA splicing, chromatin accessibility, histone...

New Insights into Adult Human Neurogenesis Confirmed

July 05, 2025

Recent research has provided compelling evidence for the continued generation of new neurons in adult human brains, settling longstanding scientific debate. Using advanced techniques, scientists...

Gut Bacteria Show Promise in Binding Toxic PFAS Chemicals

July 05, 2025

Researchers have identified certain human gut bacterial strains capable of effectively sequestering perfluoroalkyl and polyfluoroalkyl substances (PFAS), commonly known as 'forever chemicals,'...

SynHG Project Launches Effort to Build Synthetic Human Genome

July 05, 2025

Led by University of Oxford Professor Jason Chin, the newly funded SynHG project aims to develop the technologies and methodology necessary to synthesize a complete human genome from scratch over...

Breakthroughs in Glioblastoma Vaccination Show Survival Benefits

July 05, 2025

A comprehensive meta-analysis published in Journal for Immunotherapy of Cancer demonstrates vaccination therapies' potential to improve outcomes in glioblastoma multiforme (GBM), an aggressive...